
Sonoma Biotherapeutics
Best-in-class regulatory T cell therapy, delivering long-lasting, highly effective, curative treatments across a spectrum of autoimmune and degenerative diseases.
Employees
Enterprise value
$1.1—1.6b
Authorizing premium user...